Zobrazeno 1 - 10 of 17 pro vyhledávání: '"Dewi P Bakker"'
1
Pediatric acute flaccid myelitis
Autor: Jelte Helfferich, Rinze F. Neuteboom, Marit M.A. de Lange, Kimberley S.M. Benschop, Coretta C. Van Leer-Buter, Adam Meijer, Dewi P. Bakker, Eva de Bie, Hilde M.H. Braakman, Rick Brandsma, Erik H. Niks, Jikke-Mien Niermeijer, Vincent Roelfsema, Niels Schoenmaker, Lilian T. Sie, Hubert G. Niesters, Margreet J.M. te Wierik, Bart C. Jacobs, Oebele F. Brouwer
Publikováno v: Helfferich, J, Neuteboom, R F, de Lange, M M A, Benschop, K S M, van Leer-Buter, C C, Meijer, A, Bakker, D P, de Bie, E, Braakman, H M H, Brandsma, R, Niks, E H, Niermeijer, J-M, Roelfsema, V, Schoenmaker, N, Sie, L T, Niesters, H G, te Wierik, M J M, Jacobs, B C & Brouwer, O F 2023, ' Pediatric acute flaccid myelitis : Evaluation of diagnostic criteria and differentiation from other causes of acute flaccid paralysis ', European Journal of Paediatric Neurology, vol. 44, pp. 28-36 . https://doi.org/10.1016/j.ejpn.2023.03.002
European Journal of Paediatric Neurology, 44, 28-36. W.B. Saunders
European Journal of Paediatric Neurology, 44, 28-36. W.B. Saunders Ltd
European Journal of Paediatric Neurology, 44, pp. 28-36
European Journal of Paediatric Neurology, 44, 28-36
European Journal of Paediatric Neurology, 44, 28-36. ELSEVIER SCI LTD
Background: Acute flaccid paralysis (AFP) is characterized by rapidly progressive limb weakness with low muscle tone. It has a broad differential diagnosis, which includes acute flaccid myelitis (AFM), a rare polio-like condition that mainly affects
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::923617e3a98a7792a6afbf7a96c95d9f
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85150848089&origin=inward
Zobrazit plný text záznamu
2
Two newly identified CACNA1I variants linked to neurodevelopmental disorder and epilepsy differentially affect Cav3.3 gating properties
Autor: Yousra El Ghaleb, Monica L. Fernandez-Quintero, Marta Campiglio, Klaus R. Liedl, Astrid S. Plomp, Dewi P. Bakker, Mahdi M. Motazacker, Fanny Kortüm, Anne-Sophie Höing, Kerstin Kutsche, Bernhard E. Flucher
Publikováno v: Biophysical Journal, 122(3S1). Biophysical Society
el Ghaleb, Y, Fernandez-Quintero, M L, Campiglio, M, Liedl, K R, Plomp, A S, Bakker, D P, Motazacker, M M, Kortüm, F, Höing, A-S, Kutsche, K & Flucher, B E 2023, ' Two newly identified CACNA1I variants linked to neurodevelopmental disorder and epilepsy differentially affect Cav3.3 gating properties ', Biophysical Journal, vol. 122, no. 3S1, pp. 107a . https://doi.org/10.1016/j.bpj.2022.11.763
Biophysical journal, 122(3S1). Biophysical Society
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0785867673a134b4c881761afe727185
https://doi.org/10.1016/j.bpj.2022.11.763
Zobrazit plný text záznamu
3
Epidemiology of acute flaccid myelitis in children in the Netherlands, 2014 to 2019
Autor: Jelte Helfferich, Marit MA de Lange, Kimberley SM Benschop, Bart C Jacobs, Coretta C Van Leer-Buter, Adam Meijer, Dewi P Bakker, Eva de Bie, Hilde MH Braakman, Rick Brandsma, Rinze F Neuteboom, Erik H Niks, Jikke-Mien Niermeijer, Vincent Roelfsema, Niels Schoenmaker, Lilian T Sie, Hubert G Niesters, Oebele F Brouwer, Margreet JM te Wierik
Publikováno v: Eurosurveillance, 27(42). EUR CENTRE DIS PREVENTION & CONTROL
Eurosurveillance, 27(42). Centre Europeen pour la Surveillance Epidemiologique du SIDA
Helfferich, J, de Lange, M M A, Benschop, K S M, Jacobs, B C, van Leer-Buter, C C, Meijer, A, Bakker, D P, de Bie, E, Braakman, H M H, Brandsma, R, Neuteboom, R F, Niks, E H, Niermeijer, J-M, Roelfsema, V, Schoenmaker, N, Sie, L T, Niesters, H G, Brouwer, O F & te Wierik, M J M 2022, ' Epidemiology of acute flaccid myelitis in children in the Netherlands, 2014 to 2019 ', Eurosurveillance, vol. 27, no. 42 . https://doi.org/10.2807/1560-7917.ES.2022.27.42.2200157
Background Acute flaccid myelitis (AFM) is a polio-like condition affecting mainly children and involving the central nervous system (CNS). AFM has been associated with different non-polio-enteroviruses (EVs), in particular EV-D68 and EV-A71. Reliabl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af79c36bc39e70086d0914dc7c88d27f
https://doi.org/10.2807/1560-7917.es.2022.27.42.2200157
Zobrazit plný text záznamu
4
[Ventriculoperitoneal shunt dysfunction in children: various clinical presentations]
Autor: Dennis R, Buis, K Mariam, Slot, Dewi P, Bakker, René, Post, Nicole I, Wolf, W Peter, Vandertop
Publikováno v: Nederlands tijdschrift voor geneeskunde. 166
The clinical presentation of a ventriculoperitoneal shunt (VP-shunt) dysfunction depends on whether the cranial sutures are still unfused, and on the cause and severity of the VP-shunt obstruction. A suspicion of a VP-shunt dysfunction is always reas
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4f76c42a34d3c98686607d448052618a
https://pubmed.ncbi.nlm.nih.gov/36036683
Zobrazit plný text záznamu
5
A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma
Autor: Fatma E El-Khouly, Sophie E. M. Veldhuijzen van Zanten, Esther Sanchez Aliaga, W. Peter Vandertop, Dannis G. van Vuurden, N. Harry Hendrikse, Dewi P. Bakker, Gertjan J.L. Kaspers, Marc H. A. Jansen
Publikováno v: Journal of Neuro-Oncology, 153(2), 263-271. Kluwer Academic Publishers
Journal of Neuro-Oncology, 153(2), 263-271. Kluwer Academic
Journal of neuro-oncology, 153(2), 263-271. Kluwer Academic Publishers
Journal of Neuro-Oncology
El-Khouly, F E, Veldhuijzen van Zanten, S E M, Jansen, M H A, Bakker, D P, Sanchez Aliaga, E, Hendrikse, N H, Vandertop, W P, van Vuurden, D G & Kaspers, G J L 2021, ' A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma ', Journal of Neuro-Oncology, vol. 153, no. 2, pp. 263-271 . https://doi.org/10.1007/s11060-021-03763-1
Introduction This study investigates the safety, tolerability, and preliminary efficacy of combined treatment with VEGF inhibitor bevacizumab, topoisomerase I inhibitor irinotecan, and EGFR inhibitor erlotinib in children with progressive diffuse int
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b5cd964c19a4c2c73e81b5e280ec0d5
https://research.vumc.nl/en/publications/99c311f6-a6ec-4c49-9b55-1e02e59d3bb6
Zobrazit plný text záznamu
7
De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy
Autor: Marwan Shinawi, Jessica Van Ziffle, Carsten G. Bönnemann, Mohamad A. Mikati, Vandana Shashi, Konrad Platzer, Manju A. Kurian, Katy Barwick, Kathleen A. Leppig, Patrick Devine, F. Lucy Raymond, Tomi L. Toler, Johan Lundgren, Koen L.I. van Gassen, Anne Slavotinek, Saskia N. van der Crabben, Wendy K. Chung, Richard H. van Jaarsveld, Matias Wagner, Rikke S. Møller, Marie T. McDonald, Pia Zacher, Kristen Wigby, Heather C Mefford, Dewi P. Bakker, Jennifer Friedman, Angus John Clarke, Joseph T. Shieh, Holly E. Babcock, Julian R. Sampson, Amy McTague, Jamal Ghoumid, Bernt Popp, Saskia B. Wortmann, Emma Hobson, Michaela Bonfert, Gabriella Horvath, Chiara Klöckner, Virgina Lee, Cyril Mignot, Yuri A. Zarate, Jennifer A. Sullivan, Marie-José H. van den Boogaard, Johannes R. Lemke, Alba Sanchis-Juan, Tommy Stödberg, Heinrich Sticht, Eva H. Brilstra, Alyssa Gates, Caroline Nava, Nicholas Stong, Sandra Donkervoort, Alexandrea Wadley, Boris Keren, Jamie L. Fraser, Ashley C. Taylor, Jennifer Keller-Ramey
Publikováno v: Genet. Med., DOI: 10.1038/s41436-020-01020-w (2020)
Care4Rare Canada Consortium 2021, ' De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy ', Genetics in Medicine, vol. 23, no. 4, pp. 653-660 . https://doi.org/10.1038/s41436-020-01020-w
Klöckner, C, Sticht, H, Zacher, P, Popp, B, Babcock, H E, Bakker, D P, Barwick, K, Bonfert, M V, Bönnemann, C G, Brilstra, E H, Chung, W K, Clarke, A J, Devine, P, Donkervoort, S, Fraser, J L, Friedman, J, Gates, A, Ghoumid, J, Hobson, E, Horvath, G, Keller-Ramey, J, Keren, B, Kurian, M A, Lee, V, Leppig, K A, Lundgren, J, McDonald, M T, McTague, A, Mefford, H C, Mignot, C, Mikati, M A, Nava, C, Raymond, F L, Sampson, J R, Sanchis-Juan, A, Shashi, V, Shieh, J T C, Shinawi, M, Slavotinek, A, Stödberg, T, Stong, N, Sullivan, J A, Taylor, A C, Toler, T L, van den Boogaard, M J, van der Crabben, S N, van Gassen, K L I, van Jaarsveld, R H, Van Ziffle, J, Møller, R S & Care4Rare Canada Consortium 2021, ' De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy ', Genetics in Medicine, vol. 23, no. 4, pp. 653-660 . https://doi.org/10.1038/s41436-020-01020-w
Genetics in medicine, 23(4), 653-660. Lippincott Williams and Wilkins
Genetics in Medicine, 23(4), 653-660. Lippincott Williams and Wilkins
Purpose\ud This study aims to provide a comprehensive description of the phenotypic and genotypic spectrum of SNAP25 developmental and epileptic encephalopathy (SNAP25-DEE) by reviewing newly identified and previously reported individuals.\ud \ud Met
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfca6748143067988ef44bdb8b93decc
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=60808
Zobrazit plný text záznamu
8
A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma
Autor: Esther Sanchez Aliaga, C. Michel Zwaan, Fatma E El-Khouly, Sophie E. M. Veldhuijzen van Zanten, W. Peter Vandertop, Dannis G. van Vuurden, Cornelis J.A. Haasbeek, Gertjan J.L. Kaspers, Marc H. A. Jansen, Dewi P. Bakker, Nicole I. Wolf
Publikováno v: Journal of Neuro-Oncology
Journal of Neuro-Oncology, 135(2), 307-315. Kluwer Academic Publishers
Veldhuijzen van Zanten, S E M, El-Khouly, F E, Jansen, M H A, Bakker, D P, Sanchez Aliaga, E, Haasbeek, C J A, Wolf, N I, Zwaan, C M, Vandertop, W P, van Vuurden, D G & Kaspers, G J L 2017, ' A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma ', Journal of Neuro-Oncology, vol. 135, no. 2, pp. 307-315 . https://doi.org/10.1007/s11060-017-2575-9
Journal of Neuro-Oncology, 135(2), 307-315. Kluwer Academic
Journal of neuro-oncology, 135(2), 307-315. Kluwer Academic Publishers
The purpose of this phase I/II, open-label, single-arm trial is to investigate the safety, tolerability, maximum tolerated dose and preliminary efficacy of the potential radiosensitizer gemcitabine, administered concomitantly to radiotherapy, in chil
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d28103ec82d4e56c5af410b3932e028d
https://doi.org/10.1007/s11060-017-2575-9
Zobrazit plný text záznamu
10
Correction to
Autor: Esther Sanchez Aliaga, W. Peter Vandertop, Dannis G. van Vuurden, Gertjan J.L. Kaspers, Marc H. A. Jansen, Fatma E. El‑Khouly, Dewi P. Bakker, C. Michel Zwaan, Nicole I. Wolf, Sophie E. M. Veldhuijzen van Zanten, Cornelis J.A. Haasbeek
Publikováno v: Journal of Neuro-Oncology, 136(1), 219-220. Kluwer Academic Publishers
Veldhuijzen van Zanten, S E M, El-Khouly, F E, Jansen, M H A, Bakker, D P, Sanchez Aliaga, E, Haasbeek, C J A, Wolf, N I, Zwaan, C M, Vandertop, W P, van Vuurden, D G & Kaspers, G J L 2018, ' Correction to : A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma ', Journal of Neuro-Oncology, vol. 136, no. 1, pp. 219-220 . https://doi.org/10.1007/s11060-017-2636-0
In Table 2 of the original publication, there were errors in the baseline scores for the PedsQL TM 3.0 Cancer Module questionnaire, so a corrected version of Table 2 is shown in this erratum. In the subcategories of the PedsQL TM 3.0 Cancer Module qu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4693d44fdbc5a2130968d55fbc9df57c
https://doi.org/10.1007/s11060-017-2636-0
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje